/
/
HealthTree University: Relapsed and Refractory MM Treatment (Part 2 of 2)
HealthTree University: Relapsed and Refractory MM Treatment (Part 2 of 2) image
HealthTree University: Relapsed and Refractory MM Treatment (Part 2 of 2)
Posted Dec 31, 2020

Nearly everyone relapses or is refractory to myeloma therapies at some point in the course of their disease. It’s important to know your options for therapies and clinical trials, and make educated decisions about your care when it does happen.

Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. We invite you to watch them all, and also visit HealthTree University and creating a HealthTree account. By creating a HealthTree account, in HealthTree University you can:

  • Save and keep track of your progress in the courses
  • Get points for answering quiz questions
  • Bookmark videos
  • Take notes
  • Earn prizes [COMING SOON]
  • And get access to all the other incredible features of HealthTree!

 

JOIN HEALTHTREE

 

9.05 What are the newest drugs and treatments for relapsed and refractory myeloma?

 

9.06 Do individuals become refractory to a given drug or an entire class of drugs?

 

9.07 When should a patient consider a clinical trial at relapse?

 

9.08 With relapsed myeloma, when should you modifying current therapy or start a new therapy?

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Amrita Krishnan, MD, FACP of City of Hope
  • Luciano Costa, MD, PhD of University of Alabama
  • Philip McCarthy, MD of Roswell Park Comprehensive Cancer Center
  • Alexander Lesokhin, MD of Memorial Sloan Kettering Cancer Center
  • Craig Hofmeister, MD, MPH of Winship Cancer Institute of Emory University

 

Want more?

We have over 200 HealthTree University videos online at university.healthtree.org! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

Other HealthTree University Classes:

1 Myeloma Basics Part 1

2 Myeloma Basics Part 2

3 Myeloma Basics Part 3

4 Building Your Healthcare Team

5 Becoming an Empowered Patient

6 Starting Myeloma Treatment

7 Autologous Stem Cell Transplant (ASCT)

8 Precursor Conditions

9 Relapsed and Refractory MM Treatment

10 Know Your Therapy [BETA]

11 Myeloma Bone Disease

12 Blood and Urine Testing in Myeloma

13 Imaging in Myeloma

14 MRD Testing

15 Basic Genetics and Cancer Biology

16 Myeloma Genetics

17 Types of Genetic Testing in Myeloma

18 Classes of Drugs

19 COVID-19 and Multiple Myeloma [BETA]

The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University.

More HealthTree University Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811